Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Equity Ratio (2018 - 2025)

Bicycle Therapeutics (BCYC) has disclosed Equity Ratio for 8 consecutive years, with 0.81 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Equity Ratio fell 2.9% year-over-year to 0.81, compared with a TTM value of 0.81 through Sep 2025, down 2.9%, and an annual FY2024 reading of 0.83, up 33.02% over the prior year.
  • Equity Ratio was 0.81 for Q3 2025 at Bicycle Therapeutics, up from 0.8 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.84 in Q1 2025 and bottomed at 0.48 in Q2 2023.
  • Average Equity Ratio over 5 years is 0.7, with a median of 0.69 recorded in 2022.
  • The sharpest move saw Equity Ratio plummeted 30.67% in 2023, then soared 70.53% in 2024.
  • Year by year, Equity Ratio stood at 0.72 in 2021, then dropped by 8.62% to 0.66 in 2022, then decreased by 5.52% to 0.62 in 2023, then soared by 33.02% to 0.83 in 2024, then dropped by 2.32% to 0.81 in 2025.
  • Business Quant data shows Equity Ratio for BCYC at 0.81 in Q3 2025, 0.8 in Q2 2025, and 0.84 in Q1 2025.